← Browse by Condition
Medical Condition

pd l1 negative

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04468061 Phase 2
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Enrollment
110 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →